Recombinant KRT20 antibody (AA 196-323)

Catalog No. ABIN7871710

The Rabbit Monoclonal anti-KRT20 antibody (Clone KRT20-4879R) (ABIN7871710) specifically detects KRT20 in WB and IHC (p). The antibody is reactive with Human samples.

Quick Overview for Recombinant KRT20 antibody (AA 196-323) (ABIN7871710)

Target: KRT20 (Keratin 20 (KRT20))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Rabbit

Clonality: Monoclonal

Conjugate: This KRT20 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade: Carrier-free

Clone: KRT20-4879R

Product Details anti-KRT20 Antibody

Binding Specificity: AA 196-323

Purpose: Recombinant Keratin 20 Antibody / CK20 / Cytokeratin 20 (azide and preservative free)

Purification: Protein A/G affinity

Immunogen: A portion of amino acids 196-323 was used as the immunogen for the recombinant Keratin 20 antibody.

Isotype: IgG, kappa

Application Details

Application Notes: Optimal dilution of the recombinant Keratin 20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: -20 °C

Storage Comment: Aliquot the recombinant Keratin 20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for KRT20

Target: KRT20 (Keratin 20 (KRT20))

Alternative Name: Keratin 20

Background: This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900